ArticleClinical parkinsonism & related disorders2026
Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism.
Francesco Onorati et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.